Biologics manufacturers are under increasing pressure to reduce production costs. This is a key driver for moving to continuous processing, which maximizes productivity while minimizing footprint.

Continuous manufacturing is finally gaining traction in the pharmaceutical industry, but development of the necessary production technologies is, fittingly, a continuous process. Ultimately, the drawn ...

Eli Lilly’s breast cancer med Verzenio may look like your standard drug tablet—ovular, off-white, emblazoned with the dosage on the front and Lilly’s logo on the reverse—but behind that modest façade ...

ANSI/ISA-106.00.01, Procedure Automation for Continuous Process Operations, has been published by ISA. The standard sets forth mod­els, styles, strategies, philosophies, and life cycle for the ...

Advances in process analytical technology have been achieved, but significant challenges remain. Continuous API manufacturing has the potential to provide tremendous benefits to the pharmaceutical ...

Anything that you do well is worth doing better over time. The term "continuous improvement" describes a process practiced by quality engineers but it speaks to something that every conscientious ...

Due to their rodent origins, CHO cell lines can harbor endogenous retroviruses or retrovirus-like particles. Additional virus safety risks arise from the potentiality that the cell culture could be ...

The ANSI/ISA-106 standard and its supporting technical reports offer a structured approach to automating procedures in continuous process industries. Designed to reduce risk, improve consistency and ...

The Army has employed a variety of techniques for continuous process improvement (CPI) for many years. Some have resulted in projects that saved the Army millions of dollars, while other efforts have ...